Perceptive Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $15.4M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $74.1M | Sell |
|
|||||
|
2024
Q1 | $115M | Buy |
|
|||||
|
2023
Q4 | $35M | Buy |
|
|||||
|
2023
Q3 | $18.2M | Sell |
|
|||||
|
2023
Q2 | $70M | Sell |
|
|||||
|
2023
Q1 | $158M | Sell |
|
|||||
|
2022
Q4 | $212M | Buy |
|
|||||
|
2022
Q3 | $21.5M | Sell |
|
|||||
|
2022
Q2 | $26.3M | Buy |
|
|||||
|
2022
Q1 | $27.3M | Buy |
|
|||||
|
2021
Q4 | $7.32M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $474K | Sell |
|
|||||
|
2018
Q2 | $9.01M | Sell |
|
|||||
|
2018
Q1 | $16.6M | Sell |
|
|||||
|
2017
Q4 | $17.3M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $15M | Sell |
|
|||||
|
2013
Q2 | $13.4M | Buy |
|